Based on 2 analysts giving stock ratings to Viemed Healthcare Inc in the past month.
In the current month, VMD has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. VMD average Analyst price target in the last month is 12.500.
Based on analysts' estimates, VMD EPS is projected to reach 0.127 in FY2026Q3, following reported EPS of 0.072 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.07, while Viemed Healthcare IncVMD's earnings per share (EPS) for the previous quarter was USD 0.07. EPS for the next quarter is expected at USD 0.13.